217 related articles for article (PubMed ID: 17454792)
21. Disease progression following imatinib failure in gastrointestinal stromal tumors: role of surgical therapy.
Jamali FR; Darwiche SS; El-Kinge N; Tawil A; Soweid AM
Oncologist; 2007 Apr; 12(4):438-42. PubMed ID: 17470686
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and molecular characterization of gastrointestinal stromal tumors (GIST)].
Mac K; Wójcik M
Postepy Hig Med Dosw (Online); 2007 Jun; 62():272-81. PubMed ID: 18542042
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal stromal tumors: a paradigm for therapeutic options in solid organ tumors.
Novak C; Trevino JG
Mini Rev Med Chem; 2010 Jun; 10(7):624-34. PubMed ID: 20500152
[TBL] [Abstract][Full Text] [Related]
24. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model.
Gold JS; Dematteo RP
Ann Surg; 2006 Aug; 244(2):176-84. PubMed ID: 16858179
[TBL] [Abstract][Full Text] [Related]
25. [Surgery on gastrountestinal stromal tumor CD117+ (G.I.S.T.): personal experience].
Cavallaro A; Lauretta A; Cavallaro M; Pennisi S; Cavallaro V
Ann Ital Chir; 2006; 77(2):137-41. PubMed ID: 17147087
[TBL] [Abstract][Full Text] [Related]
26. Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.
Lee JL; Kim JY; Ryu MH; Kang HJ; Chang HM; Kim TW; Lee H; Park JH; Kim HC; Kim JS; Kang YK
Dig Dis Sci; 2006 Jun; 51(6):1043-6. PubMed ID: 16865565
[No Abstract] [Full Text] [Related]
27. Imaging characteristics of liver metastasis from gastrointestinal stromal tumor before and after imatinib mesylate treatment.
Ulusan S; Koç Z; Kayaselçuk F
Turk J Gastroenterol; 2008 Jun; 19(2):129-32. PubMed ID: 19110671
[TBL] [Abstract][Full Text] [Related]
28. Multidisciplinary treatment of gastrointestinal stromal tumors.
Kingham TP; DeMatteo RP
Surg Clin North Am; 2009 Feb; 89(1):217-33, x. PubMed ID: 19186237
[TBL] [Abstract][Full Text] [Related]
29. [Imatinib and solid tumours].
Arifi S; El Sayadi H; Dufresne A; Ray-Coquard I; Fayette J; Méeus P; Ranchère D; Decouvelaere AV; Alberti L; Tabone-Eglinger S; Blay JY; Cassier P
Bull Cancer; 2008 Jan; 95(1):99-106. PubMed ID: 18230575
[TBL] [Abstract][Full Text] [Related]
30. New strategies for treating GIST when imatinib fails.
Boyar MS; Taub RN
Cancer Invest; 2007 Aug; 25(5):328-35. PubMed ID: 17661208
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal stromal tumors: rationale for surgical adjuvant trials with imatinib.
Cormier JN; Patel SR; Pisters PW
Curr Oncol Rep; 2002 Nov; 4(6):504-9. PubMed ID: 12354363
[TBL] [Abstract][Full Text] [Related]
32. Complete remission of recurrent gastrointestinal stromal tumors after treatment with imatinib: report of a case.
Kobayashi M; Okamoto K; Nakatani H; Okabayashi T; Namikawa T; Ichikawa K; Kitagawa H; Araki K
Surg Today; 2006; 36(8):727-32. PubMed ID: 16865518
[TBL] [Abstract][Full Text] [Related]
33. Advanced gastrointestinal stromal tumor patients with complete response after treatment with imatinib mesylate.
Chiang KC; Chen TW; Yeh CN; Liu FY; Lee HL; Jan YY
World J Gastroenterol; 2006 Apr; 12(13):2060-4. PubMed ID: 16610057
[TBL] [Abstract][Full Text] [Related]
34. [A case of gastrointestinal stromal tumor of the stomach with rapid growth in a short term].
Okada K; Maruyama K; Nagase H; Matsunaga H; Ide Y; Ota H; Murata K; Yokouchi H; Nakamichi I; Kinuta M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2080-2. PubMed ID: 19106530
[TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal stromal tumors and the evolution of targeted therapy.
Sanborn RE; Blanke CD
Clin Adv Hematol Oncol; 2005 Aug; 3(8):647-57. PubMed ID: 16167051
[TBL] [Abstract][Full Text] [Related]
36. Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors.
De Giorgi U; Aliberti C; Benea G; Conti M; Marangolo M
Clin Cancer Res; 2005 Sep; 11(17):6171-6. PubMed ID: 16144917
[TBL] [Abstract][Full Text] [Related]
37. [Imatinib mesylate (glivec) as a treatment for gastrointestinal stromal tumor (GIST)--long term follow-up].
Raccah E; Merimsky O; Kuten A; Apter S; Catane R
Harefuah; 2007 May; 146(5):329-34, 408. PubMed ID: 17674545
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal stromal tumors: chemotherapy and imatinib.
Muler JH; Baker L; Zalupski MM
Curr Oncol Rep; 2002 Nov; 4(6):499-503. PubMed ID: 12354362
[TBL] [Abstract][Full Text] [Related]
39. [Consensus on the medical treatment of gastrointestinal stromal tumors].
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):875-7. PubMed ID: 18396652
[No Abstract] [Full Text] [Related]
40. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]